Mark Frohlich
Member Board of Directors @Rigel Pharmaceuticals Inc.
Seattle, WA, US
EMAILS
MOBILE NUMBERS
+91 *********19
Signup · Get unlimited contacts
WORK HISTORY
Mar 2025 — Present
Member Board of Directors @Rigel Pharmaceuticals Inc.
View department →
EDUCATION
1994 — 1997
University of California, San Francisco
Oncology Fellowship Program
1990 — 1994
University of California, San Francisco
Internal Medicine Residency Program, Chief Residency
1980 — 1984
Yale University
BS
1986 — 1990
Harvard Medical School
Doctor of Medicine - MD
1984 — 1985
Swiss Federal Institute of Technology
Computer Engineering
ABOUT MARK FROHLICH
Medical oncologist with deep drug development & translational research experience. Expertise in immuno-oncology & cell therapy. Experience with drug approvals in US & EU, and reimbursement & commercialization challenges.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.